Citations 1
CXC chemokine receptor 4 (CXCR4) targeted gold nanoparticles potently enhance radiotherapy outcomes in breast cancer
Bhattarai, Shanta, Mackeyev, Yuri , Venkatesulu, Bhanu Prasad , Singh, Pankaj K. , Mackeyev, Yuri , Bhattarai, Shanta, Krishnan, Sunil
Nanoscale | October 19, 2021 | Volume: 13 | Issue: 45 | Pages: 19056-19065
CXC chemokine receptor 4 (CXCR4) is overexpressed on most breast cancer cell surfaces including triple negative breast cancer (TNBC) which lacks traditional receptor overexpression.